Edition:
United Kingdom

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

635.65INR
25 Mar 2019
Change (% chg)

-- (--)
Prev Close
Rs635.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
850,829
52-wk High
Rs711.90
52-wk Low
Rs493.50

Latest Key Developments (Source: Significant Developments)

Glenmark Pharmaceuticals Gets ANDA Approval For Clindamycin And Benzoyl Peroxide Gel
Friday, 15 Mar 2019 

March 15 (Reuters) - Glenmark Pharmaceuticals Ltd ::SAYS GETS ANDA APPROVAL FOR CLINDAMYCIN AND BENZOYL PEROXIDE GEL.  Full Article

Glenmark Pharmaceuticals Gets ANDA Approval For Clobetasol Propionate Foam
Monday, 18 Feb 2019 

Feb 18 (Reuters) - Glenmark Pharmaceuticals Ltd ::SAYS RECEIVES ANDA APPROVAL FOR CLOBETASOL PROPIONATE FOAM.  Full Article

India's Glenmark Pharmaceuticals Dec-Qtr Profit Rises
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - Glenmark Pharmaceuticals Ltd ::DEC QUARTER CONSOL PROFIT FROM CONTINUING OPERATIONS 1.16 BILLION RUPEES VERSUS PROFIT OF 1.05 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR DEC QUARTER CONSOL PROFIT WAS 2.28 BILLION RUPEES.DEC QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 25.55 BILLION RUPEES VERSUS 22.04 BILLION RUPEES LAST YEAR.  Full Article

Glenmark Pharmaceuticals Approves Spin Off Its Innovation Business Into New Company
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - Glenmark Pharmaceuticals Ltd ::GAVE IN-PRINCIPLE APPROVAL TO SPIN OFF INNOVATION BUSINESS INTO A NEW COMPANY IN US.NEW INNOVATION COMPANY WILL FOCUS ON THERAPEUTIC AREAS OF IMMUNOLOGY, ONCOLOGY AND PAIN MANAGEMENT..SAYS NEW INNOVATION COMPANY WILL BE A WHOLLY-OWNED SUBSIDIARY OF GLENMARK AND WILL BE BASED IN THE US..NEW COMPANY WILL HAVE OVER 400 EMPLOYEES AS PART OF THIS BUSINESS.GLENMARK PHARMACEUTICALS - SPECIALTY AND GENERICS BUSINESS WILL CONTINUE TO BE HOUSED IN PARENT CO AND WILL NOT BE PART OF THIS NEW COMPANY.THE NEW INNOVATION CO WILL BE BASED IN U.S. & WILL HAVE INDEPENDENT BOARD AND NEW CEO.  Full Article

Glenmark Pharmaceuticals Gets Tentative ANDA Approval For Fulvestrant Injection
Thursday, 7 Feb 2019 

Feb 7 (Reuters) - Glenmark Pharmaceuticals Ltd ::SAYS CO RECEIVES TENTATIVE ANDA APPROVAL FOR FULVESTRANT INJECTION, 250 MG/5 ML.  Full Article

Glenmark Pharmaceuticals Gets Tentative ANDA Approval For Topiramate Extended-Release Capsules
Thursday, 24 Jan 2019 

Jan 24 (Reuters) - Glenmark Pharmaceuticals Ltd ::SAYS CO GETS TENTATIVE ANDA APPROVAL FOR TOPIRAMATE EXTENDED-RELEASE CAPSULES.  Full Article

Glenmark Pharmaceuticals Enters Into Licensing Agreement With Yuhan Corp
Thursday, 10 Jan 2019 

Jan 10 (Reuters) - Glenmark Pharmaceuticals Ltd ::SAYS ENTERS INTO AN EXCLUSIVE LICENSING AGREEMENT WITH YUHAN CORPORATION.DEAL WITH YUHAN CORP TO COMMERCIALIZE INVESTIGATIONAL SEASONAL ALLERGIC RHINITIS NASAL SPRAY RYALTRIS IN SOUTH KOREA.CO TO BE RESPONSIBLE FOR MANUFACTURING AND SUPPLY OF PRODUCT, WHILE YUHAN WILL BE RESPONSIBLE FOR REGULATORY FILING.CO WILL RECEIVE AN UPFRONT PAYMENT, REGULATORY AND COMMERCIAL MILESTONE PAYMENTS AS WELL AS ROYALTIES FROM YUHAN.  Full Article

Glenmark Pharmaceuticals Gets ANDA Approval For Fluocinolone Acetonide Oil
Tuesday, 18 Dec 2018 

Dec 18 (Reuters) - Glenmark Pharmaceuticals Ltd ::SAYS RECEIVES ANDA APPROVAL FOR FLUOCINOLONE ACETONIDE OIL, 0.01%.  Full Article

Glenmark Pharmaceuticals Gets ANDA Approval For Hydrocortisone Valerate Ointment
Monday, 17 Dec 2018 

Dec 17 (Reuters) - Glenmark Pharmaceuticals Ltd ::SAYS RECEIVES ANDA APPROVAL FOR HYDROCORTISONE VALERATE OINTMENT USP, 0.2%.  Full Article

Glenmark Pharmaceuticals Gets Tentative ANDA Nod For Clobetasol Propionate Foam, 0.05 Pct
Monday, 26 Nov 2018 

Nov 26 (Reuters) - Glenmark Pharmaceuticals Ltd ::SAYS GETS TENTATIVE ANDA APPROVAL FOR CLOBETASOL PROPIONATE FOAM, 0.05%.  Full Article

Photo

Novartis's new treatment for hives outperforms Xolair in trials

ZURICH Novartis said on Tuesday it was taking its experimental medicine ligelizumab to late-stage trials after the drug showed signs of outperforming existing product Xolair in treating severe urticaria, also known as hives.